Everything you need to know about Mounjaro before you decide

How Mounjaro works, and why two receptors matter

Most people researching Mounjaro have heard it described as a "weight-loss injection", which is accurate but tells you little about why it produces the results it does. Tirzepatide, the active molecule, binds to receptors for two gut hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both are released after eating and play roles in signalling fullness, slowing the rate at which food leaves the stomach, and regulating blood sugar. Activating both pathways together appears to reinforce the appetite-suppressing signal more effectively than targeting either one alone.

The practical result for most people is a meaningful reduction in hunger and a stronger sense of fullness from smaller portions. Cravings tend to quieten too, though this varies person to person. None of this replaces a sensible diet or regular movement (the licence specifically requires both alongside treatment) but many people find the medicine makes those changes considerably easier to sustain. You can read more about the mechanism and the clinical background on our tirzepatide overview page.

One point worth understanding early: the 2.5 mg starting dose is not a therapeutic dose in the usual sense. Its job is to give your digestive system time to adapt before the dose climbs. Most people notice little weight change in the first four weeks. That is expected.

What the trial evidence actually says about results

The headline figures come from SURMOUNT-1, published in the New England Journal of Medicine, a 72-week trial in 2,539 adults with obesity but without type 2 diabetes. At the highest dose (15 mg), average body-weight reduction was around 20–21%. To put that in perspective: a 100 kg person losing 20% would weigh 80 kg by the end of treatment. These are averages across a large trial population; individual results vary, and no outcome is guaranteed.

A later head-to-head study, SURMOUNT-5, compared tirzepatide directly against semaglutide 2.4 mg (the active ingredient in Wegovy) over 72 weeks. Tirzepatide produced greater average weight reduction. NICE considered this evidence in its appraisal and recommended tirzepatide for NHS use in eligible adults, though NHS access is phased and criteria are strict. For those who do not meet NHS thresholds or prefer not to wait, a private prescription route through a regulated pharmacy is the alternative.

Results take time. Most people reach their maintenance dose gradually, and the meaningful weight-loss phase typically unfolds across months rather than weeks. If you want a straightforward look at how to judge whether the treatment is doing its job, our page on how to tell if Mounjaro is working covers the signs worth tracking.

Who Mounjaro is licensed for, and what the prescriber considers

The UK licence covers adults with a BMI of 30 or above, or 27 or above if they have at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes or type 2 diabetes. For some ethnic backgrounds, UK guidance applies thresholds 2.5 kg/m² lower. The NHS BMI calculator is a useful starting point if you are unsure where you sit.

BMI alone does not decide suitability. A prescriber also looks at your medical history, current medicines, and any conditions that might affect how safely you can use the treatment. If you would like a thorough grounding in what this medicine is before your consultation, our page covering everything about Mounjaro is a good place to start. Mounjaro is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for under-18s. A history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) requires prescriber discussion, as do certain gastrointestinal conditions and a history of pancreatitis.

Women taking oral contraceptives should know that tirzepatide can temporarily reduce pill absorption: adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase is the guidance. If you are on HRT, transdermal forms (patches or gels) are worth discussing with your doctor for the same reason. These are not reasons to avoid treatment; they are things a thorough prescriber factors in, which is precisely why a clinical consultation matters.

Cost, access, and what starting treatment looks like

Mounjaro is a prescription-only medicine, there is no legal way to obtain it without a clinical assessment confirming suitability. On the NHS, access is currently limited by phased eligibility criteria tied to BMI and the number of weight-related conditions present; for most people, private treatment through a registered online pharmacy is the practical route. If you are still weighing up whether this treatment is right for you, our comprehensive guide covering all aspects of Mounjaro brings together the key information in one place. A sensible breakdown of what private treatment typically costs, and what to look for in any price you are quoted, is on our Mounjaro cost guide.

At nume, the process runs like this: you complete a free consultation, a GPhC-registered Independent Prescriber reads your answers the same day, identity and weight are verified, and if the prescriber approves treatment, your first pen is dispatched the same day (for orders placed before midday, Monday to Friday) and arrives with DPD the next working day in plain packaging. It is worth knowing that orders placed on a Friday afternoon or before a bank holiday will ship on the next working day, worth factoring in if payday timing matters to you.

Every repeat order goes back through clinical review. No subscriptions, no automatic renewals. If you would like to keep up with the latest developments around this treatment, our Mounjaro news page covers updates as they emerge. And if you have questions about our pharmacy's registration or clinical team, you can read about them on our about us page.

When you are ready to take the next step, speak to our prescribers through a free consultation, no commitment, just a proper clinical conversation about whether Mounjaro is right for you.